54 related articles for article (PubMed ID: 16859784)
21. Changes in Proteome Profile of Peripheral Blood Mononuclear Cells in Chronic Chagas Disease.
Garg NJ; Soman KV; Zago MP; Koo SJ; Spratt H; Stafford S; Blell ZN; Gupta S; Nuñez Burgos J; Barrientos N; Brasier AR; Wiktorowicz JE
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004490. PubMed ID: 26919708
[TBL] [Abstract][Full Text] [Related]
22. Markers of oxidative stress in adipose tissue during Trypanosoma cruzi infection.
Wen JJ; Nagajyothi F; Machado FS; Weiss LM; Scherer PE; Tanowitz HB; Garg NJ
Parasitol Res; 2014 Sep; 113(9):3159-65. PubMed ID: 24948102
[TBL] [Abstract][Full Text] [Related]
23. MnSODtg mice control myocardial inflammatory and oxidative stress and remodeling responses elicited in chronic Chagas disease.
Dhiman M; Wan X; Popov VL; Vargas G; Garg NJ
J Am Heart Assoc; 2013 Oct; 2(5):e000302. PubMed ID: 24136392
[TBL] [Abstract][Full Text] [Related]
24. Carvedilol enhances the antioxidant effect of vitamins E and C in chronic Chagas heart disease.
Budni P; Pedrosa RC; Dalmarco EM; Dalmarco JB; Frode TS; Wilhelm Filho D
Arq Bras Cardiol; 2013 Oct; 101(4):304-10. PubMed ID: 24008655
[TBL] [Abstract][Full Text] [Related]
25. Innate immune responses and antioxidant/oxidant imbalance are major determinants of human Chagas disease.
Dhiman M; Coronado YA; Vallejo CK; Petersen JR; Ejilemele A; Nuñez S; Zago MP; Spratt H; Garg NJ
PLoS Negl Trop Dis; 2013; 7(8):e2364. PubMed ID: 23951383
[TBL] [Abstract][Full Text] [Related]
26. Defects of mtDNA replication impaired mitochondrial biogenesis during Trypanosoma cruzi infection in human cardiomyocytes and chagasic patients: the role of Nrf1/2 and antioxidant response.
Wan X; Gupta S; Zago MP; Davidson MM; Dousset P; Amoroso A; Garg NJ
J Am Heart Assoc; 2012 Dec; 1(6):e003855. PubMed ID: 23316324
[TBL] [Abstract][Full Text] [Related]
27. Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.
Machado FS; Dutra WO; Esper L; Gollob KJ; Teixeira MM; Factor SM; Weiss LM; Nagajyothi F; Tanowitz HB; Garg NJ
Semin Immunopathol; 2012 Nov; 34(6):753-70. PubMed ID: 23076807
[TBL] [Abstract][Full Text] [Related]
28. Cardiac-oxidized antigens are targets of immune recognition by antibodies and potential molecular determinants in chagas disease pathogenesis.
Dhiman M; Zago MP; Nunez S; Amoroso A; Rementeria H; Dousset P; Nunez Burgos F; Garg NJ
PLoS One; 2012; 7(1):e28449. PubMed ID: 22238578
[TBL] [Abstract][Full Text] [Related]
29. Proteome expression and carbonylation changes during Trypanosoma cruzi infection and Chagas disease in rats.
Wen JJ; Garg NJ
Mol Cell Proteomics; 2012 Apr; 11(4):M111.010918. PubMed ID: 22199233
[TBL] [Abstract][Full Text] [Related]
30. Would selenium supplementation aid in therapy for Chagas disease?
Jelicks LA; de Souza AP; Araújo-Jorge TC; Tanowitz HB
Trends Parasitol; 2011 Mar; 27(3):102-5. PubMed ID: 21212020
[TBL] [Abstract][Full Text] [Related]
31. Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.
Muñoz-Saravia SG; Haberland A; Wallukat G; Schimke I
Heart Fail Rev; 2012 Jan; 17(1):45-64. PubMed ID: 21165698
[TBL] [Abstract][Full Text] [Related]
32. Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease.
Francisco AF; de Abreu Vieira PM; Arantes JM; Silva M; Pedrosa ML; Elói-Santos SM; Martins-Filho OA; Teixeira-Carvalho A; Araújo MS; Tafuri WL; Carneiro CM
Redox Rep; 2010; 15(4):185-90. PubMed ID: 20663295
[TBL] [Abstract][Full Text] [Related]
33. Phenyl-alpha-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic Rats.
Wen JJ; Gupta S; Guan Z; Dhiman M; Condon D; Lui C; Garg NJ
J Am Coll Cardiol; 2010 Jun; 55(22):2499-508. PubMed ID: 20510218
[TBL] [Abstract][Full Text] [Related]
34. Trypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes.
Ba X; Gupta S; Davidson M; Garg NJ
J Biol Chem; 2010 Apr; 285(15):11596-606. PubMed ID: 20145242
[TBL] [Abstract][Full Text] [Related]
35. Oxidative Stress in Chagas Disease.
Gupta S; Wen JJ; Garg NJ
Interdiscip Perspect Infect Dis; 2009; 2009():190354. PubMed ID: 19547716
[TBL] [Abstract][Full Text] [Related]
36. Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease.
Dhiman M; Estrada-Franco JG; Pando JM; Ramirez-Aguilar FJ; Spratt H; Vazquez-Corzo S; Perez-Molina G; Gallegos-Sandoval R; Moreno R; Garg NJ
Clin Vaccine Immunol; 2009 May; 16(5):660-6. PubMed ID: 19297613
[TBL] [Abstract][Full Text] [Related]
37. Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: implications in Chagas' disease.
Dhiman M; Nakayasu ES; Madaiah YH; Reynolds BK; Wen JJ; Almeida IC; Garg NJ
Am J Pathol; 2008 Sep; 173(3):728-40. PubMed ID: 18688021
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress in chronic cardiopathy associated with Chagas disease.
de Oliveira TB; Pedrosa RC; Filho DW
Int J Cardiol; 2007 Apr; 116(3):357-63. PubMed ID: 16859784
[TBL] [Abstract][Full Text] [Related]
39. Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease.
Maçao LB; Wilhelm Filho D; Pedrosa RC; Pereira A; Backes P; Torres MA; Fröde TS
Int J Cardiol; 2007 Dec; 123(1):43-9. PubMed ID: 17328977
[TBL] [Abstract][Full Text] [Related]
40. Antioxidant therapy attenuates oxidative insult caused by benzonidazole in chronic Chagas' heart disease.
Ribeiro CM; Budni P; Pedrosa RC; Farias MS; Parisotto EB; Dalmarco EM; Fröde TS; Oliveira-Silva D; Colepicolo P; Filho DW
Int J Cardiol; 2010 Nov; 145(1):27-33. PubMed ID: 19625091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
